CRTO Form 144: Brian Gleason plans $65K share sale after recent disposals
Rhea-AI Filing Summary
Criteo S.A. (NASDAQ: CRTO) insider Brian Gleason has filed a Form 144 indicating his intent to sell up to 2,842 ordinary shares through Citigroup Global Markets on or after 07/28/2025. At the filing price this represents an aggregate value of roughly $64,936, or less than 0.01 % of the company’s 53.1 million shares outstanding, suggesting limited dilution.
The shares were acquired via restricted and performance stock vesting on 04/28/2022 and are to be sold as compensation-related stock. Gleason has already disposed of 5,327 shares in the last three months—2,841 shares on 04/28/2025 for $96,268.99 and 2,486 shares on 05/23/2025 for $64,175.21—bringing his total recent and proposed sales to 8,169 shares (~$225 k). The filing affirms he holds no undisclosed material adverse information about the company.
Positive
- None.
Negative
- Insider selling: Brian Gleason plans to sell 2,842 shares, adding to 5,327 shares already sold this quarter, which may be perceived as a mild negative signal.
Insights
TL;DR: Small Form 144; minor insider sale, immaterial to float, neutral impact.
The planned 2,842-share sale equates to just 0.005 % of shares outstanding and follows two similarly sized sales earlier this quarter. While insider disposals can be a sentiment head-wind, the dollar amounts (≈$65 k current, ≈$225 k including recent sales) are immaterial to Criteo’s $2 bn+ market cap and do not alter the investment thesis. No new information on operations, guidance, or financials is provided, and the transaction appears to stem from routine equity compensation. I therefore view the filing as not impactful for valuation or liquidity.